Hepatitis B virus-related liver disease in isolated anti-hepatitis B-core positive lymphoma patients receiving chemo- or chemo-immune therapy.
Clara
C
Targhetta
Maria Giuseppina
MG
Cabras
Angela Maria
AM
Mamusa
Gabriella
G
Mascia
Emanuele
E
Angelucci
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal / Q000494:pharmacology; D058846:Antibodies, Monoclonal, Murine-Derived; D004358:Drug Therapy / Q000379:methods; D005260:Female; D006509:Hepatitis B / Q000378:metabolism / Q000821:virology*; D006512:Hepatitis B Core Antigens / Q000378:metabolism*; D006515:Hepatitis B virus / Q000378:metabolism*; D006801:Humans; D007155:Immunologic Factors / Q000494:pharmacology; D008223:Lymphoma / Q000188:drug therapy* / Q000276:immunology / Q000378:metabolism / Q000821:virology*; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D006512:Hepatitis B Core Antigens; D007155:Immunologic Factors; D000069283:Rituximab